Cargando…
Prolactin Inhibits BCL6 Expression in Breast Cancer Cells through a MicroRNA-339-5p-Dependent Pathway
PURPOSE: Prolactin (PRL) plays a critical role in breast cancer progression by activating its cognate receptor and promotes the growth and differentiation of breast cancer cells. Studies have shown that B-cell lymphoma 6 (BCL6) is the target gene of microRNA-339-5p (miR-339-5p) and that BCL6 express...
Autores principales: | Yan, Hong, Zhao, Min, Huang, Shan, Chen, Ping, Wu, Wen-yong, Huang, Jin, Wu, Zheng-sheng, Wu, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822104/ https://www.ncbi.nlm.nih.gov/pubmed/27066093 http://dx.doi.org/10.4048/jbc.2016.19.1.26 |
Ejemplares similares
-
miR-339-5p inhibits lung adenocarcinoma invasion and migration by directly targeting BCL6
por: Li, Peng, et al.
Publicado: (2018) -
MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling
por: Zhang, Cen, et al.
Publicado: (2014) -
MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689
por: Zeng, Hui, et al.
Publicado: (2019) -
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
por: Vannini, Ivan, et al.
Publicado: (2017) -
MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis
por: Wu, Zheng-sheng, et al.
Publicado: (2010)